Biogen Idec Photos

Exterior RTP
Bird's Eye View
Interior RTP

+ Add Photo

Biogen Idec Reviews

266 Reviews
Rating Trends
Recommend to a friend
Approve of CEO
Biogen Idec CEO and Director George A. Scangos
George A. Scangos
152 Ratings

Biogen Idec Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    No Offer
    Negative Experience
    Average Interview
    No Offer
    Negative Experience
    Average Interview


    I applied through a recruiter. The process took 6 weeksinterviewed at Biogen Idec in March 2013.


    Contacted by third party recruiter who set up a telephone screening interview. A couple of telephone interviews followed as the manager was in a different province and due to fast-paced timing could not meet in person. They were on an unrealistic timeframe for hiring, but as such moved very quickly and invited me to Toronto for an array of in person interviews with HR, hiring manager, CEO, etc. To meet their schedule I took the red-eye and flew overnight from Western Canada. Process was well handled and interviews went well and the company seemed very adaptable and fast acting. However, they then took weeks to call me back and did so only to ask for another telephone interview and five minutes before this interview they informed the recruiter that this interview was for a different position. After that there was no further follow-up and they did not return calls to the recruiter. I know someone else who was left completely hanging with absolutely no follow-up after travelling to Toronto for interviews.

    Interview Questions

    • Develop a 30-60-90 day plan. I thought they would ask specific questions, but when I got there they just asked me to present the plan and barely said anything.   Answer Question

Biogen Idec Awards and Accolades

Something missing? Add an award
Top Employer, Science Magazine, 2012
Top Employer, Science Magazine, 2011
Show More

Additional Info

Unlock Profile
Headquarters Cambridge, MA
Size 5000+ Employees
Founded 1978
Type Company - Public (BIIB)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 billion (CAD) per year
Competitors Unknown

With its pipeline full of biotech drugs, Biogen Idec aims to meet the unmet needs of patients around the world. The biotech giant is focused on developing treatments in the areas of immunology and neurology. Its product roster includes best-selling Avonex, a popular drug for the treatment of relapsing multiple sclerosis (MS); Tysabri, a drug treatment for MS and Crohn's disease (developed with Elan); Rituxan, a monoclonal antibody developed jointly with Genentech that treats non-Hodgkin's lymphoma and rheumatoid arthritis; and Fumaderm, a psoriasis drug marketed in... More

Work at Biogen Idec? Share Your Experiences

Biogen Idec

Click to Rate